← Leaderboards
Georgirene Vladutiu
State University Of New York At Buffalo
$2,065,267
Attributed
$2,120,267
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $514.6K · FY2008–12$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,120,267 · 2
By mechanism
R01$2,010,266 · 1
R41$110,001 · 1
Top collaborators
- Kenneth M Kaufman1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Gene D Morse$10,749,384
- Jason A Sprowl$2,753,770
- Mulchand S Patel$5,167,977
- David M Dietz$7,195,683
- Robert J Genco$8,762,775
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationScreening ProcedureHealth Care CostsMusclePharmaceutical PreparationsSamplingGenerationsGenetic VariantLeadMorbidity - Disease RateAnesthesia ProceduresMyopathyPredispositionRisk FactorsCost EffectivenessGeneral PopulationBaseGeneticCholesterolInheritedLifeMetabolicControl GroupsSeverities
Grant awards (6)
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$393,028
R01 · FY2012 · HL · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$403,573
R01 · FY2011 · HL · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$404,555
R01 · FY2010 · HL · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$404,555
R01 · FY2009 · HL · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$404,555
R01 · FY2008 · HL · contact PI
Comprehensive Genotyping for Susceptibility to Metabolic Muscle Disease$110,001
R41 · FY2008 · HL